Phase I trial of myeloablative conditioning with 3‐day total marrow and lymphoid irradiation for leukemia

This prospective phase I trial aimed to determine the recommended dose of 3‐day total marrow and lymphoid irradiation (TMLI) for a myeloablative conditioning regimen by increasing the dose per fraction. The primary end‐point of this single‐institution dose escalation study was the recommended TMLI d...

Descripción completa

Detalles Bibliográficos
Autores principales: Ogawa, Hiroaki, Konishi, Tatsuya, Najima, Yuho, Kito, Satoshi, Hashimoto, Shimpei, Kato, Chika, Sakai, Satoshi, Kanbara, Yasuhiro, Atsuta, Yuya, Konuma, Ryosuke, Wada, Atsushi, Murakami, Daisuke, Nakasima, Shiori, Uchibori, Yusuke, Onai, Daishi, Hamamura, Atsushi, Nishijima, Akihiko, Shingai, Naoki, Toya, Takashi, Shimizu, Hiroaki, Kobayashi, Takeshi, Ohashi, Kazuteru, Doki, Noriko, Murofushi, Keiko Nemoto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
ORIGINAL ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9899623/
https://www.ncbi.nlm.nih.gov/pubmed/36221800
http://dx.doi.org/10.1111/cas.15611

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9899623/
https://www.ncbi.nlm.nih.gov/pubmed/36221800
http://dx.doi.org/10.1111/cas.15611

Ejemplares similares